Genitourinary Drugs

 decision foresight.png

Global Genitourinary Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030


Genitourinary drugs are used for the treatment of disorders related to kidney, urinary bladder, ureters, and urethra. These disorders are mainly caused due to damage to the urinary tract or the genital organs. Genitourinary infections caused by bacteria and yeast may be communicable. Growing incidences of genitourinary infections and cancers in the urinary system are playing a major role in driving the genitourinary drugs market. Genitourinary drugs have substituted the usage of immunosuppressant and steroids used during genitourinary disorders. This is because their consumption resulted in severe side-effects like vomiting, nausea, and diarrhoea. The global Genitourinary drugs market accounted approximate USD 30.4 billion in 2020 and it is expected to reach USD 30.2 billion by 2030 with a CAGR of 0.50% during forecast period.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020191

Market Dynamics and Factors:

Rising cases of genitourinary disorders, growing cases of urinary cancer, and increasing occurrence of sexually transmitted diseases are the major factors driving the growth of the genitourinary drugs market. For instance, according to the Centre for Disease Control and Prevention (CDC), over 2.3 million Americans in the U.S were diagnosed with sexually transmitted diseases in 2017. Additionally, the increasing awareness regarding impotency and urinary incontinence is also attributing towards the market growth of genitourinary drugs. Technological advancements in drug research and increasing strategic collaborations among major players in the market is expected to create more opportunities for market growth in the coming future. For instance, Bristol-Myers Squibb collaborated with Nektar Therapeutics to assess the collective efficacy of NKTR-214 and Opdivo for treating five types of tumour, and bladder cancer in September 2016. However, certain factors like lack of compliance to medication, rising cases of drug counterfeiting, and drug patent expirations may restrain the market growth of genitourinary drugs in the forecast period. Moreover, the evolution of novel drugs such as Cialis has propelled the growth of the global genitourinary drugs market. Novel drugs are more effective than multiple-therapy drugs and are less costly compared to them. The success of Cialis has intensified further development of novel drugs which in turn has attributed towards the growth of the market.

Market Segmentation:

  • Global Genitourinary Drugs Market – By Product Type

    • Urologicals

    • Hormonal Therapy

    • Gynaecological

    • Anti-Infective

    • Others

  • Global Genitourinary Drugs Market – By Indication 

    • Prostate Cancer

    • Ovarian Cancer

    • Bladder Cancer

    • Cervical Cancer

    • Renal Cancer

    • Erectile Dysfunction

    • Urinary Tract Infections

    • Sexually Transmitted Diseases

    • Haematuria And Others

  • Global Genitourinary Drugs Market – By End-User 

    • Hospitals

    • Super-Speciality Centers

    • Clinics

    • Others

  • Global Genitourinary Drugs Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020191

Geographic Analysis:

North America is expected to dominate the genitourinary market during the forecast period in terms of market share. The major factors responsible for such domination are high prevalence of major genitourinary disorders and cancers in the region; awareness regarding impotence & urinary incontinence; robust healthcare infrastructure; and presence of major drug manufacturers in the region. Europe is expected to be the second most dominating market for genitourinary drugs during the forecast period. Government investments in healthcare; rising geriatric population leading to chronic urinary diseases; and increased R&D activities in the region are the major factors attributing for the market growth in the European region. The Asia Pacific region is anticipated to witness the fastest growth during the forecast period. Rising disposable incomes leading to increasing demand for genitourinary drugs in APAC region; continuous improvements in healthcare facilities; and high R&D investments by global players in APAC region are the major factors behind the rapid growth of the market in this region. 

Competitive Scenario:

The key players operating in the global genitourinary drugs market are –

Pfizer, GlaxoSmithKline, Bristol-Myers Squibb Co., Hoffman-La Roche Inc., Abbott Laboratories, Merck & Co., Novartis AG, Ionis Pharmaceuticals Inc., Antares Pharma, Bayer AG, Allergan, Teva Pharmaceutical Industries Ltd.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020191 

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Genitourinary Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Genitourinary Drugs Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Genitourinary Drugs Market most.

  4. The data analysis present in the Global Genitourinary Drugs Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Genitourinary Drugs Market business.

The 2021 Annual Global Genitourinary Drugs Market offers:

  • 100+ charts exploring and analysing the Global Genitourinary Drugs Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Genitourinary Drugs Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020191 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

Comments

Post a Comment

Popular posts from this blog

Digital Pathology

Image
  Global Digital Pathology Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Global Digital Pathology Market accounted USD 721.7 million in 2020 and is anticipated to reach USD 2281.7469 million by 2030, at a CAGR of 12.2% during the forecast period. It is an innovation predominantly committed to minimize laboratory expenses, increase operational efficiency, improving treatment decisions and patient care, and improved overall productivity. This technique incorporates the management, acquisition, sharing and interpretation of pathology information — which include slides and data — in a digital environment. Digital slides are produced when glass slides are apprehended with a scanning device, to deliver a high-resolution digital image that can be observed on a computer screen or mobile device. Virtual microscopy is a part of the market which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer m...
Read more

Global Antisense And RNAi Therapeutics Market

Image
  Global Antisense And RNAi Therapeutics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Antisense and RNAi therapeutics are therapeutic treatments having the potential to treat diseases such as chronic liver and cardiovascular diseases, and other rare diseases. Antisense RNAi was the largest technology segment in 2018 due to technological advancement in the healthcare sector. Antisense technology is a method that can stop protein production. Antisense technology can be used to design new therapeutics for certain new diseases. The principle behind is antisense nucleic acid sequence base pairs with complementary sense RNA strand and avoids from being translated into a protein. Based on the triggering of the RNA molecules this technology is segmented into siRNA and miRNA. Antisense and RNAi therapeutics services are applicable in the treatment of a wide range of diseases that target nucleic acid and affect the cell growth cycle. miRNA has the ability to restore gen...
Read more

Regenerative Therapies

Image
  Global Regenerative Therapies Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030 The Global regenerative therapies market held USD 8.5 billion in 2020 and is to grow with a CAGR of 15.7% from 2020-2030. Regenerative medicine is medicine principle that focuses on the replacement of tissues, human cells and organs in order to restore normal functionality. Regenerative medicine aims to renew or replace cells in the damaged and unfitting tissue or organ of human beings. The body's own cells can be encouraged to cure, or a patient with laboratories-grown cells and tissues can be therapied. It can treat incurable chronic disorders and conditions such as Alzheimer's disease, Parkinson's disease, diabetes, cardiac illness, kidney failure, osteoporosis and injuries to the spinal cord, etc. Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Tabl...
Read more